The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first two seasons of use, according to a new study.

Robust immune responses were observed among healthy and high-risk younger adults who received the Ad26/protein RSV preF vaccine.

Pfizer has bolstered the evidence behind its respiratory syncytial virus (RSV) vaccine with a positive trial of the shot used to protect newborns, adding to earlier results in older adults. The ...

What are the lasting impacts of RSV, and how can you prevent your infant from getting the infection? Dr. Stephania Cormier is ...

GSK and Pfizer’s full-year financial results show that the former is currently winning the battle for take-up of their rival respiratory syncytial virus (RSV) vaccines, although, there are signs ...

Respiratory syncytial virus (RSV) is a leading cause of respiratory infections in infants and a significant cause of respiratory infections in the elderly and adults with chronic obstructive ...

Future Virology. 2014;9(8):753-767. CHF: Congestive heart failure; CLD: Chronic lung disease; F: Fusion; G: Glyco; GLA-SE: Glucopyranosyl lipid A-stable emulsion; GMT ...

HHS Secretary Robert F. Kennedy Jr. is preparing to remove committee members who advise the government on vaccine approvals ...

Pfizer’s decision to halt further marketing of Beqvez is further sign of the sparse patient interest in gene therapies for the bleeding condition.

In a solution containing both DR3 and plate-bound TL1A, several doses of anti-TL1A neutralizing antibody were added, with Tulisokibart serving as a positive control. As the concentration increases ...

For the antigen, high-quality full-length human CD20 virus-like ... FcγRIIIA V158 E) FcγRIIIA F158; F) FcγRIIIB. Image Credit: ACROBiosystems RTX has shown strong complement-dependent ...

ROME (AP) — Pope Francis had breakfast, read the newspapers and followed Mass on television Sunday after a second night sleeping well at the hospital where the 88-year-old pontiff is being ...